Chemical inhibitors of L-type Ca++ CP γ2 include a variety of calcium channel blockers that directly target the activity of this protein. Verapamil, a well-known calcium channel blocker, inhibits L-type Ca++ CP γ2 by occluding the channel's pore, thereby preventing calcium ions from entering the cell. This action effectively halts the translocation of calcium ions that L-type Ca++ CP γ2 would normally facilitate. Similarly, Diltiazem achieves inhibition by binding to L-type Ca++ CP γ2 and promoting a closed state of the channel, which stops the flow of calcium ions into the cell. Nifedipine also shares this mechanism, specifically blocking the L-type calcium channels integral to the functionality of L-type Ca++ CP γ2, thus impeding calcium ion flow.
Continuing with this trend, Amlodipine and Isradipine function as L-type Ca++ CP γ2 inhibitors by selectively obstructing the calcium channels to reduce calcium entry into cells. This inhibition is critical to the regulation of calcium ion transport mediated by L-type Ca++ CP γ2. Nicardipine and Nimodipine further contribute to the inhibition of L-type Ca++ CP γ2 by targeting the L-type calcium channels, with Nimodipine having a pronounced effect on the calcium channels present in cerebral arteries. Felodipine and Lacidipine inhibit calcium currents by blocking the calcium channels associated with L-type Ca++ CP γ2, leading to decreased calcium conductance. Lercanidipine also selectively inhibits these calcium channels, resulting in reduced calcium entry into cells. Finally, Manidipine and Azelnidipine contribute to the inhibition profile of L-type Ca++ CP γ2 by selectively antagonizing L-type calcium channels, effectively diminishing the translocation of calcium ions across the cellular membrane where L-type Ca++ CP γ2 is localized. Each of these chemicals, by targeting the calcium channels specifically associated with the protein, ensures a decrease in the intracellular calcium levels that L-type Ca++ CP γ2 is responsible for regulating.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is a calcium channel blocker that inhibits L-type Ca++ channels, including L-type Ca++ CP γ2 by blocking the pore through which Ca++ ions pass. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem inhibits L-type Ca++ CP γ2 by binding to the channel and stabilizing the closed conformation, preventing Ca++ influx. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine specifically inhibits L-type Ca++ CP γ2 by blocking the L-type calcium channels, thus impeding the flow of Ca++ ions. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
Amlodipine selectively inhibits L-type Ca++ CP γ2 by blocking calcium channels and reducing calcium entry into cells. | ||||||
Isradipine | 75695-93-1 | sc-201467 sc-201467A | 10 mg 50 mg | $88.00 $324.00 | 1 | |
Isradipine binds to L-type Ca++ CP γ2 and inhibits calcium ion translocation through the channel, blocking the resultant currents. | ||||||
Nicardipine hydrochloride | 54527-84-3 | sc-202731 sc-202731A | 1 g 5 g | $33.00 $83.00 | 5 | |
Nicardipine inhibits L-type Ca++ CP γ2 by selectively blocking L-type calcium channels, which are responsible for calcium influx. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
Nimodipine can inhibit L-type Ca++ CP γ2 by preferentially blocking L-type calcium channels in cerebral arteries, reducing calcium entry. | ||||||
Felodipine | 72509-76-3 | sc-201483 sc-201483A | 10 mg 50 mg | $91.00 $222.00 | 1 | |
Felodipine acts as an inhibitor to L-type Ca++ CP γ2 by selectively blocking the calcium channels associated with this protein, inhibiting Ca++ conductance. | ||||||
trans Lacidipine | 103890-78-4 | sc-213066 | 10 mg | $153.00 | ||
Lacidipine inhibits L-type Ca++ CP γ2 through its action as a calcium channel antagonist, reducing calcium currents through these channels. | ||||||
Manidipine | 89226-50-6 | sc-211774 | 10 mg | $278.00 | ||
Manidipine inhibits L-type Ca++ CP γ2 by selectively blocking the L-type calcium channels that the protein forms, reducing calcium influx. | ||||||